CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 53,412	$ 58,669	$ 73,928
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for credit losses	9,826	15,698	(1,273)
Depreciation and amortization of premises and equipment	6,878	6,943	6,865
Net gain (loss) on sales and disposals of premises and equipment	56	(5,059)	295
Non-cash lease expense (income)	159	13	(401)
Cash flows from operating leases	(5,073)	(5,095)	(5,896)
Amortization of mortgage servicing rights	776	705	1,295
Net amortization and accretion of premium/discount on investment securities	1,766	3,049	4,395
Share-based compensation expense	2,072	1,636	3,273
Net loss (gain) on sales of investment securities	9,934	2,074	(8,506)
Net gain on sales of residential mortgage loans	(1,257)	(721)	(1,778)
Proceeds from sales of loans held for sale	68,339	39,950	80,237
Origination of loans held for sale	(70,966)	(39,902)	(76,033)
Equity in earnings of unconsolidated entities	21	22	(184)
Distributions from unconsolidated entities	0	51	237
Net increase in cash surrender value of bank-owned life insurance	(6,619)	(5,366)	(10)
Deferred income tax expense	8,771	11,211	25,810
Net tax benefit from share-based compensation	57	154	146
Amortization and impairment of intangible assets	1,461	0	0
Net change in other assets and liabilities	10,906	21,080	11,721
Net cash provided by operating activities	90,519	105,112	114,121
Cash flows from investing activities:
Purchases of available-for-sale investment securities	(253,580)	(47,393)	(89,058)
Proceeds from maturities, prepayments and calls of available-for-sale investment securities	57,371	60,101	168,224
Proceeds from sales of available-for-sale and equity investment securities	96,562	29,476	8,506
Purchases of held-to-maturity investment securities	0	0	(20,041)
Proceeds from maturities, prepayments and calls of held-to-maturity investment securities	41,690	39,099	33,469
Loan payments (originations), net	131,598	111,012	(133,501)
Purchases of loan portfolios	(49,443)	(19,659)	(323,402)
Proceeds from sales of loans originated for investment	9,397	9,629	0
Purchases of bank-owned life insurance	(3,008)	0	(1,300)
Proceeds from bank-owned life insurance death benefits	4,117	2,627	2,491
Net purchases of premises and equipment	(15,092)	(12,650)	(18,440)
Proceeds from sales of premises and equipment	0	6,216	0
Net return of capital from unconsolidated entities	0	495	0
Contributions to unconsolidated entities	(18,822)	(1,645)	(10,249)
Net proceeds from (purchases) redemption of FHLB stock	(136)	2,353	(1,182)
Net cash provided by (used in) investing activities	654	179,661	(384,483)
Cash flows from financing activities:
Net (decrease) increase in deposits	(203,581)	111,369	97,065
Net (decrease) increase in FHLB advances and other short-term borrowings	0	(5,000)	5,000
Proceeds from long-term debt	0	50,000	0
Cash dividends paid on common stock	(28,143)	(28,117)	(28,505)
Repurchases of common stock	(945)	(2,632)	(20,740)
Net proceeds from issuance of common stock and stock option exercises	0	0	679
Net cash (used in) provided by financing activities	(232,669)	125,620	53,499
Net (decrease) increase in cash and cash equivalents	(141,496)	410,393	(216,863)
Cash and cash equivalents at beginning of year	522,437	112,044	328,907
Cash and cash equivalents at end of year	380,941	522,437	112,044
Cash paid during the year for:
Interest expense paid	103,263	58,448	13,476
Income taxes (received) paid, net	(9,213)	7,313	5,581
Supplemental non-cash disclosures:
Net change in common stock held by directors' deferred compensation plan	0	0	(2,041)
Net transfer of investment securities from available-for-sale to held-to-maturity at fair value	0	0	675,177
Right-of-use lease assets obtained in exchange for lease liabilities	5,117	0	0
Amortization of unrealized losses on investment securities transferred to held-to-maturity at fair value	7,159	7,440	4,295
Other intangible assets and services provided in exchange for Swell common stock	0	0	1,500
Other intangible assets received in exchange for Swell common stock	$ 0	$ 1,500	$ 0

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.